29. Li X, Xu Z, Ji L, Guo L, Liu J, Feng K, Xu Y, Zhu D, Jia W, Ran X, Chen L,Zhao S, Shi B, Zhu J, Shan Z, Zhou Z, Zeng L, Weng J*; cooperative group on Direct Medical Cost Investigation of Diabetes in Chinese Urban Tertiary Hospitals, Chinese Diabetes Society. Direct medical costs for patients with type 2 diabetes in 16 tertiary hospitals in urban China: A multicenter prospective cohort study. J Diabetes Investig. 2019 Mar;10(2):539-551. https://doi.org/10.1111/jdi.12905.

Pre One:30. Jia W*, Weng J*, Zhu D, Ji L, Lu J, Zhou Z, Zou D, Guo L, Ji Q, Chen L, Chen L, Dou J, Guo X, Kuang H, Li L, Li Q, Li X, Liu J, Ran X, Shi L, Song G, Xiao X,Yang L, Zhao Z; Chinese Diabetes Society. Standards of medical care for type 2 diabetes in China 2019. Diabetes Metab Res Rev. 2019 Sep;35(6):e3158. https://doi.org/10.1002/dmrr.3158.

Next One:41. Zhang Y, Xu F, Liang H, Cai M, Wen X, Li X, Weng J*. Exenatide inhibits the growth of endometrial cancer Ishikawa xenografts in nude mice. Oncol Rep. 2016 Mar;35(3):1340-8. https://doi.org/10.3892/or.2015.4476.